01 · Process stage
PlannedSample handling & preparation
Define secure sample transfer, storage conditions and preparation steps before analytical testing.
Capabilities · Analytical & stability services
Sterility, endotoxin & particulate testing
A proposed analytical service domain for parenteral products, connecting sample preparation, critical testing environments, method validation and the interpretation of final results.
PlannedCatalogue scope
Service statusPlanned
Planned.
Technical boundaries and readiness need confirmation before an activity could be presented as available.
Basis · Catalogue scope
- Status
- PlannedNo available service asserted
- Source-plan relationship
- Catalogue scopeProposed catalogue expansion
- Readiness
- Not establishedProduct and process evidence needed
- Facility roadmap
- First commercial batch target Q1 2028 · indicativeNot a service date
01 · Proposed service scope
Start with the product and its container.
Sterility, endotoxin and particulate testing is presented as a planned service domain. The specific container presentation, product characteristics and analytical technique would determine the exact scope.
The initial project plan focuses on manufacturing modules for sterile products. The proposed services catalogue adds the corresponding analytical domains, which would require separate scope confirmation.
Membrane filtration, direct inoculation and kinetic endotoxin methods are distinct disciplines. Inclusion in a common catalogue does not establish that one analytical route is suitable for all sterile presentations.
Catalogue boundary
A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.
02 · Presentation families
Match the route to the format.
| Format | Planning note | Basis | Status |
|---|---|---|---|
| Aseptic presentationsAseptic filling of vials | Testing scope for products prepared through aseptic processing and filtration. | Catalogue scope | Planned |
| Terminally sterilised productsTerminal sterilisation | Analytical evaluation for items subjected to final terminal sterilisation cycles. | Catalogue scope | Planned |
| Raw materials & biologicsProtein raw-material production & purification | Endotoxin and bioburden evaluation for critical input materials and biological substances. | Catalogue scope | Planned |
| Medical devicesDevice assembly | Particulate matter and endotoxin assessment for relevant product-contact components. | Catalogue scope | Planned |
03 · Process scope for discussion
Make the sequence and its evidence visible.
02 · Process stage
PlannedMethod suitability assessment
Determine the absence of analytical interference and validate the specific recovery method.
03 · Process stage
PlannedTesting environment control
Establish the necessary cleanroom conditions, isolator parameters and continuous environmental monitoring activities.
04 · Process stage
PlannedRoutine analytical execution
Perform the defined test procedure under strict aseptic controls and documented parameters.
05 · Process stage
PlannedIncubation & reading
Manage precise temperature controls, required durations and the systematic evaluation of samples.
06 · Process stage
PlannedData review & reporting
Connect the environmental data, analytical records and final results for formal disposition.
Illustrative sequence
This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.
04 · Supporting services
No service stands alone.
01PlannedInitial project scope
Aseptic filling of vials
Product preparation, filling, closure and visual-inspection scope.
Explore proposed scope02PlannedCatalogue scope
Microbiological testing
Methods, materials and facility conditions relevant to the proposed activity.
Explore proposed scope03PlannedCatalogue scope
Terminal sterilisation
Suitability of the product, container and proposed sterilisation process.
Explore proposed scope05 · Readiness questions
A service claim needs a defined evidence base.
- Product definition
- Exact formulation, container characteristics and the applicable compendial testing requirements.
- Facility controls
- Qualified isolators, cleanrooms and appropriately controlled and monitored laboratory environments.
- Analytical evidence
- Validated methods, inhibition studies and established criteria for particulate matter.
- Quality responsibilities
- Accountability for environmental excursions, data integrity and final test results.
- Regulatory context
- Applicable pharmacopoeial standards governing sterile product evaluation and acceptance.
- Technical agreement
- Defined analytical responsibilities, reporting boundaries and material transfer protocols.
06 · Practical questions
Before a technical discussion.
Is this service currently available?
No. The service is Planned. This page is a scope proposal and does not establish an operating sterility or endotoxin testing service.
Does this analytical testing belong to the initial Boten plan?
No. The initial plan focuses on formulation and filling modules. This testing scope is a proposed catalogue addition requiring separate technical confirmation.
What information helps define the question?
Identify the specific dosage form, analytical method, testing environment requirements and the technical question. Confidential data should only be shared through an agreed route.
Is there a service launch quarter?
No. No service-specific quarter is established. The project-wide indicative milestones do not commit any individual analytical service to a start date.
Does a technical discussion establish supply?
No. Feasibility, scope, permissions, validated analytical evidence and any agreement would need to be established before a service commitment.
Professional enquiries
Discuss a defined question.
Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.